Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Since HIV-1 is a retrovirus with a high mutation rate and recombination rate, the virus contains a variety of genotypes and recombinants. The men who have sex with men (MSM) population in Beijing has become the main group of HIV transmission, and the co-transmission of multiple HIV-1 subtypes in the same high-risk group has led to the continuous generation of recombinants between various subtypes. In this study, two unique recombinant forms were identified in the samples from Beijing, and the full-length sequences were amplified and sequenced for analysis. Through the construction of phylogenetic trees and recombination breakpoint analysis, the two recombinants were identified as second-generation recombinants composed of CRF01_AE and CRF07_BC. The emergence of more complex recombinant strains poses new challenges to HIV prevention, and it is necessary to focus on monitoring the epidemic in the MSM population.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/aid.2024.0098 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
First Identification of a Novel HIV-1 CRF80_0107/B Recombinant Form Among Men Who Have Sex with Men in Hebei Province, China.
AIDS Res Hum Retroviruses
September 2025
Clinical Laboratory, The People's Hospital of Baoding, Baoding, China.
The emergence of CRF80_0107 resulted from recombination between co-circulating CRF01_AE and CRF07_BC genotypes. To date, no secondary recombinants involving CRF80_0107 as a parental strain have been documented in public sequence databases. Here, we report the identification and characterization of a novel HIV-1 CRF80_0107/B recombinant form isolated from a treatment-naïve men who have sex with men (MSM) individual in Baoding City, Hebei Province, China.
View Article and Find Full Text PDFMolecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment-naïve individuals with HIV-1 in Türkiye.
HIV Med
September 2025
Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Türkiye.
Introduction: Monitoring transmitted drug resistance is crucial for guiding first-line antiretroviral therapy (ART) and controlling the rising HIV epidemic in Türkiye. This study aimed to determine the prevalence of transmitted antiretroviral resistance to protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), integrase strand transfer inhibitors (INSTIs) and capsid assembly inhibitors (CAIs). We also assessed the distribution of HIV-1 subtypes and circulating recombinant forms (CRFs) at one of the main national referral centres in Türkiye.
View Article and Find Full Text PDFPARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancer.
Mol Oncol
September 2025
Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Prostate cancer (PCa) is the second most lethal cancer in men in the US. African American (AA) men have twice the incidence and death rate of European American (EA) men. Advanced PCa shows increased expression and activity of the DNA damage/repair pathway enzyme, poly (ADP-ribose) polymerase 1 (PARP1).
View Article and Find Full Text PDFStudy of Testosterone and Recombinant Human Growth Hormone in Facioscapulohumeral Muscular Dystrophy.
Neurol Genet
October 2025
Department of Neurology, University of Rochester, NY.
Background And Objectives: Effective therapies for facioscapulohumeral muscular dystrophy (FSHD) are currently limited. Recombinant human growth hormone (rHGH) combined with testosterone (combination therapy) may have meaningful clinical effects on ambulation, strength, muscle mass, and disease burden. As such, combination therapy has the potential to limit disease progression and functional decline in individuals with muscular dystrophy.
View Article and Find Full Text PDFCharacterization of Two Novel HIV-1B/CRF01_AE/CRF07_BC Recombinant Forms Among Men Who Have Sex with Men in Hebei Province, China.
AIDS Res Hum Retroviruses
September 2025
Clinical Laboratory, The People's Hospital of Baoding, Baoding, China.
The frequent recombination between subtypes has driven significant HIV-1 genetic diversity in recent years, especially in some areas with co-circulation of multiple subtypes. In this study, we obtained nearly full-length genome sequences of two novel HIV-1 B/CRF01_AE/CRF07_BC recombinants from BD076A and BDL161, with lengths of 8718 bp (HXB2:772-9490) and 8851 bp (HBB2:759-9610), respectively. Both recombination breakpoint and Bootscanning analysis revealed that the recombinant structure of BD076A was based on the CRF07_BC backbone, with the insertion of one subtype B and one CRF01_AE gene fragment, containing four subregions.
View Article and Find Full Text PDF